Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector

Vaccine

Volumn 28, Issue 5, 2010, Pages 1234-1240

  Kim, Dae Sun ^a   Cho, Young Joo ^a   Kim, Byoung Guk ^b   Lee, Su Hae ^b   Nam, Jae Hwan ^a  

^a The Catholic University of Korea   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

Attenuation; Coxsackievirus; Viral vaccine vector

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN E2; LIVE VACCINE; PROTEIN VP4; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VECTOR; YYFF CDNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS; CYTOTOXIC T LYMPHOCYTE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC CODE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOBLOTTING; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTENUATION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODY FORMATION; CERCOPITHECUS AETHIOPS; COS CELLS; ENTEROVIRUS B, HUMAN; GENE EXPRESSION; HELA CELLS; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HUMANS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL ENVELOPE PROTEINS; VIRAL HEPATITIS VACCINES;

EID: 74249108852     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.017     Document Type: Article

References (26)

1. Alexander B., and Lgor M.B. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?. Expert Rev Vaccines 1 2 (2002) 233-245
2. Rueckert R.R. Fundamental virology. third ed. (1996), Lippincott-Raven Publishers, Philadelphia
3. Molla A., Jang S.K., Paul A.V., Reuer Q., and Wimmer E. Cardioviral internal ribosomal entry site is functional in a genetically engineered dicistronic poliovirus. Nature 356 6366 (1992) 255-257
4. Chapman N., Tu Z., Tracy S., and Gauntt C. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol 135 1-2 (1994) 115-130
5. Tracy S., Chapman N., and Tu Z. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch Virol 122 3-4 (1992) 399-409
6. Höfling K., Tracy S., Chapman N., Kim K.S., and Leser J.S. Expression of an antigenic adenovirus epitope in a group B coxsackievirus. J Virol 74 10 (2000) 4570-4578
7. Chapman N.M., Kim K.S., Tracy S., Jackson J., Höfling K., Leser J.S., et al. Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin. J Virol 74 17 (2000) 7952-7962
8. Halim S.S., Collins D.N., and Ramsingh A.I. A therapeutic HIV vaccine using coxsackie-HIV recombinants: a possible new strategy. AIDS Res Hum Retroviruses 16 15 (2000) 1551-1558
9. Henke A., Zell R., Ehrlich G., and Stelzner A. Expression of immunoregulatory cytokines by recombinant Coxsackievirus B3 variants confers protection against virus-induced myocarditis. J Virol 75 17 (2001) 8187-8194
10. Park J.H., Kim D.S., Cho Y.J., Kim Y.J., Jeong S.Y., Lee S.M., et al. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis. Vaccine 27 13 (2009) 1974-1983
11. Kim S.M., Park J.H., Chung S.K., Kim J.Y., Hwang H.Y., Chung K.C., et al. Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death. J Virol 78 24 (2004) 13479-13488
12. Yanagi M., Purcell R.H., Emerson S.U., and Hukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94 16 (1997) 8738-8743
13. Lim B.K., Shin J.O., Lee S.C., Kim D.K., Choi D.J., Choe S.C., et al. Long-term cardiac gene expression using a coxsackieviral vector. J Mol Cell Cardiol 38 5 (2005) 745-751
14. Kim Y.J., Yun S.H., Lim B.K., Park K.B., Na H.N., Jeong S.Y., et al. Systemic analysis of a novel coxsackievirus gene delivery system in a mouse model. J Microbiol Biotechnol 19 3 (2009) 307-313
15. Forns X., Emerson S.U., Tobin G.J., Mushahwar I.K., Purcell R.H., and Bukh J. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface. Vaccine 17 15-16 (1999) 1992-2002
16. Forns X., Allander T., Rohwer-Nutter P., and Bukh J. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface. Virology 274 1 (2000) 75-85
17. 3-mediated heart disease. Nat Med 6 4 (2000) 429-434
18. Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol 13 17 (2007) 2406-2415
19. Shimizu A., Igarashi H., Kiyphara T., Cabezon T., Farci P., Purcell R.H., et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223 2 (1996) 409-412
20. Matsumori A., Yamada T., Suzuki H., Matoba Y., and Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72 6 (1994) 561-566
21. Satoh M., Tamura G., Segawa I., Tashiro A., Hiramori K., and Satodate R. Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch 427 5 (1996) 503-509
22. Schmidtke M., Gluck B., Merkle I., Hofmann P., Stelzner A., and Gemsa D. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis. J Med Virol 61 4 (2000) 518-526
23. Helle F., Wychowski C., Vu-Dac N., Gustafson K.R., Voisset C., and Dubuisson J. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J Biol Chem 281 35 (2006) 25177-25183
24. Andino R., Silvera D., Suggett S.D., Achacoso P.L., Miller C.J., Baltimore D., et al. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science 265 5177 (1994) 1448-1451
25. Mueller S., and Wimmer E. Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardiovirus like open reading frames. J Virol 72 1 (1998) 20-31
26. Henke A., Jarasch N., Martin U., Zell R., and Wutzler P. Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-γ. Viral Immunol 21 1 (2008) 38-48